아시아 태평양 만성 질환 관리 시장 – 2028년까지의 산업 동향 및 예측

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

아시아 태평양 만성 질환 관리 시장 – 2028년까지의 산업 동향 및 예측

  • Healthcare
  • Published Report
  • Jun 2021
  • Asia-Pacific
  • 350 Pages
  • 테이블 수: 109
  • 그림 수: 45

>아시아 태평양 만성 질환 관리 시장, 유형별(솔루션 및 서비스), 솔루션 유형(온프레미스 솔루션, 클라우드 기반 솔루션, 웹 기반), 서비스 유형(교육 서비스, 구현 서비스, 컨설팅 서비스 및 기타), 질병 유형(심혈관 질환(CVD), 당뇨병, 만성 폐쇄성 폐 질환(COPD), 관절염, 천식, 암 및 기타), 최종 사용자(의료 서비스 제공자, 의료비 지불자, 기타), 국가별(중국, 한국, 일본, 인도, 호주, 싱가포르, 말레이시아, 인도네시아, 태국, 필리핀, 기타 아시아 태평양 지역) 산업 동향 및 2028년까지의 예측

아시아 태평양 만성 질환 관리 시장

시장 분석 및 통찰력 : 아시아 태평양 만성 질환 관리 시장

만성 질환 관리 시장은 2021년에서 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년에서 2028년까지의 예측 기간 동안 15.8%의 CAGR로 성장하고 있으며 2028년까지 14,329.15백만 달러에 도달할 것으로 예상된다고 분석했습니다. 만성 질환의 유병률이 증가함에 따라 고급 만성 질환 관리 솔루션과 서비스가 필요하므로 만성 질환 관리 시장 성장의 원동력이 됩니다.

만성 질환 관리(CDM)는 만성 건강 상태의 영향을 받는 개인에게 매일 더 잘 관리하는 데 필요한 의료, 지식, 기술 및 리소스를 제공하는 지속적인 관리 및 지원입니다. 주로 다양한 소프트웨어 및 서비스를 통해 제공됩니다. 만성 질환 관리란 통합 관리를 통해 질병의 영향을 예방하거나 최소화하여 만성 질환이 있는 개인의 의료 비용을 줄이고 삶의 질을 향상시키는 데 도움이 됩니다.

노령 인구의 증가와 만성 질환의 유병률 증가는 만성 질환 관리 시장의 원동력으로 작용합니다. 클라우드 기반 솔루션에 대한 보안 우려는 만성 질환 관리 솔루션에 대한 수요를 낮추어 만성 질환 관리 시장 성장을 제한하고 있습니다. 새로운 기술 발전의 급증은 만성 질환 관리 시장에 기회로 작용합니다. 그러나 저소득 및 중소득 국가에서 접근성이 부족하여 만성 질환 관리 시장 성장에 어려움이 있습니다.

만성 질환 관리 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 만성 질환 관리 시장 시나리오를 이해하려면 Data Bridge Market Research에 연락하여 분석가 브리핑을 요청하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.

아시아 태평양 만성 질환 관리 시장

만성 질환 관리 시장 범위 및 시장 규모

The chronic disease management market is segmented on the basis of the type, solution type, service type, disease indiacation and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the chronic disease management market is segmented into solution and services. In 2021, solution segment is expected to dominate the chronic disease management market due to rising per capita income of Asian countries specially developing countries in Asia-Pacific.
  • On the basis of solution type, the chronic disease management market is segmented into on-premise solution, cloud-based solution and web-based. In 2021, on-premise solution segment is expected to dominate the chronic disease management market due to rise in demand for advanced chronic disease solutions.
  • On the basis of service type, the chronic disease management market is segmented into education service, implementation service, consulting service and others. In 2021, implementation services segment is expected to dominate the chronic disease management market due to growing strategic initiative by major key market players.
  • On the basis of disease indication, the chronic disease management market is segmented into cardiovascular diseases (CVD), diabetes, chronic obstructive pulmonary disorders (COPD), arthritis, asthma, cancer and others. In 2021, cardiovascular diseases (CVD) segment is expected to dominate the chronic disease management market due to rising aging population in countries like China and India which increases the prevalence of cardiovascular diseases (CVD).
  • On the basis of end user, the chronic disease management market is segmented into healthcare providers, healthcare payers and others. In 2021, healthcare providers segment is expected to dominate the chronic disease management market due to growing healthcare expenditure in Asian countries.

Chronic Disease Management Market Country Level Analysis

The chronic disease management market is analyzed and market size information is provided by the country, type, solution type, service type, disease type and end user as referenced above.

The countries covered in the chronic disease management market report are the China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines and rest of Asia-Pacific.

China is expected to dominate the market due to rise in prevalence of chronic diseases and geriatric population along with increase in per capita income.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growing Strategic Activities by Major Market Players to Enhance the Awareness for Chronic Disease Management, is Boosting the Market Growth of Chronic Disease Management market.

The chronic disease management market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.

Competitive Landscape and Chronic Disease Management Market Share Analysis

Chronic disease management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to chronic disease management market.

The major companies which are dealing in the chronic disease management are Health Catalyst, Cedar Gate Technologies, Koninklijke Philips N.V., WellSky, ZeOmega, Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Asia-Pacific Solutions Ltd., NXGN Management, LLCVivify Health, Inc., MINES & Associates, Inc., Casenet, LLC., ExlService Holdings, Inc., cliexa, Inc., ScienceSoft USA Corporation, Allscripts Healthcare LLC, Infosys Limited, Medecision, and IBM Corporation among others domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the chronic disease management market.

For instance,

  • In April 2021, WellSky launched advanced home health visit management solution. The new addition CareInsights Guidance provides actionable visit utilization insights to balance the care quality and patient health improvement. It is predicted that, this solution launch will provide benefits to their patients, staff, and leading to upsurge the sales growth of the company.
  • 2020년 12월, HGS AxisPoint Health(Hinduja Global Solutions Ltd.의 자회사)는 Parkland Community Health Plan(PCHP)과 파트너십을 맺었습니다. 이 파트너십의 주요 목적은 텍사스 북부의 약 195,000명의 Medicaid 수혜자에게 질병 관리 서비스를 제공하는 것이었습니다. 이를 통해 글로벌 시장에서 회사의 입지를 강화하여 회사의 매출 성장을 급증시켰습니다.

협력, 제품 출시, 사업 확장, 수상 및 인정, 합작 투자 및 시장 참여자의 기타 전략을 통해 만성 질환 관리 시장에서 회사의 입지를 강화하고 조직의 수익 성장에도 도움이 됩니다.


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET END USER COVERAGE GRID

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: REGULATIONS

5.1 REGULATION IN THE UNITED STATES:

5.2 GOVERNING REGULATIONS:

5.3 CPT CODES:

5.4 PRACTITIONER ELIGIBILITY:

5.5 PATIENT ELIGIBILITY:

5.6 REQUIREMENTS:

5.7 REGULATIONS IN EUROPE:

5.8 NATIONAL STRATEGY AND LEAD ORGANIZATIONS FOR HEALTHCARE SERVICES IN EUROPE:

5.9 DATA PRIVACY PROTECTION IN EUROPE:

5.1 REGULATIONS IN INDIA:

5.11 RELEVANT ACTS FOR THIS FRAMEWORK:

5.12 DATA PRIVACY PROTECTION IN INDIA:

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES

6.1.2 GROWING GERIATRIC POPULATION

6.1.3 RISING PER CAPITA INCOME

6.1.4 ADVANCEMENT IN HEALTHCARE INFRASTRUCTURE AND INITIATIVE ACTIVITIES BY GOVERNMENT ORGANIZATION

6.2 RESTRAINTS

6.2.1 HIGH COST OF SERVICES

6.2.2 SECURITY CONCERNS WITH CLOUD-BASED SOLUTIONS

6.3 OPPORTUNITIES

6.3.1 SURGE IN NOVEL TECHNOLOGICAL ADVANCEMENTS

6.3.2 RISING HEALTHCARE EXPENDITURE

6.3.3 INCREASED REIMBURSEMENT POLICIES

6.3.4 RISING DISEASE MANAGEMENT PROGRAMS

6.4 CHALLENGE

6.4.1 LACK OF ACCESSIBILITY

7 IMPACT OF COVID-19 ON THE ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET

7.1 IMPACT ON PRICE

7.2 IMPACT ON DEMAND

7.3 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS

7.4 CONCLUSION

8 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE

8.1 OVERVIEW

8.2 SOLUTION

8.3 SERVICES

9 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE

9.1 OVERVIEW

9.2 ON PREMISE SOLUTION

9.3 WEB BASED SOLUTION

9.4 CLOUD BASED SOLUTION

10 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE

10.1 OVERVIEW

10.2 IMPLEMENTATION SERVICES

10.3 CONSULTING SERVICES

10.4 EDUCATION SERVICES

10.5 OTHERS

11 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION

11.1 OVERVIEW

11.2 CARDIOVASCULAR DISEASES (CVD)

11.3 DIABETES

11.4 CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD)

11.5 ASTHMA

11.6 ARTHRITIS

11.7 CANCER

11.8 OTHERS

12 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY END USER

12.1 OVERVIEW

12.2 HEALTHCARE PROVIDERS

12.2.1 HOSPITALS, PHYSICIAN GROUPS, INTEGRATED DELIVERY

12.2.2 DIAGNOSTIC & IMAGING CENTERS

12.2.3 AMBULATORY CARE CENTERS

12.2.4 HOME HEALTHCARE AGENCIES, NURSING HOMES & ASSISTED LIVING FACILITIES

12.2.5 OTHERS

12.3 HEALTHCARE PAYERS

12.3.1 PUBLIC PAYERS

12.3.2 PRIVATE PAYERS

12.4 OTHERS

13 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET BY REGION

13.1 ASIA-PACIFIC

13.1.1 CHINA

13.1.2 JAPAN

13.1.3 AUSTRALIA

13.1.4 INDIA

13.1.5 SOUTH KOREA

13.1.6 SINGAPORE

13.1.7 MALAYSIA

13.1.8 THAILAND

13.1.9 INDONESIA

13.1.10 PHILIPPINES

13.1.11 REST OF ASIA-PACIFIC

14 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

15 SWOT ANALYSIS

16 COMPANY PROFILES

16.1 IBM CORPORATION

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 SERVICE PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 KONINKLIJKE PHILIPS N.V.

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 COGNIZANT

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 ALLSCRIPTS HEALTHCARE, LLC

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 SOLUTION PORTFOLIO

16.4.5 RECENT DEVELOPMENTS

16.5 ALTRUISTA HEALTH

16.5.1 COMPANY SNAPSHOT

16.5.2 SOLUTION PORTFOLIO

16.5.3 RECENT DEVELOPMENTS

16.6 CASENET, LLC

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT & SERVICE PORTFOLIO

16.6.3 RECENT DEVELOPMENTS

16.7 CEDAR GATE TECHNOLOGIES

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENT

16.8 CLIEXA, INC.

16.8.1 COMPANY SNAPSHOT

16.8.2 SOLUTION PORTFOLIO

16.8.3 RECENT DEVELOPMENTS

16.9 EPIC SYSTEMS CORPORATION

16.9.1 COMPANY SNAPSHOT

16.9.2 SERVICE PORTFOLIO

16.9.3 RECENT DEVELOPMENT

16.1 EXLSERVICE HOLDINGS, INC.

16.10.1 COMPANY SNAPSHOT

16.10.2 REVENUE ANALYSIS

16.10.3 SERVICE PORTFOLIO

16.10.4 RECENT DEVELOPMENTS

16.11 HEALTH CATALYST

16.11.1 COMPANY SNAPSHOT

16.11.2 REVENUE ANALYSIS

16.11.3 PRODUCT PORTFOLIO

16.11.4 RECENT DEVELOPMENT

16.12 HINDUJA ASIA-PACIFIC SOLUTIONS LTD.

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.4 RECENT DEVELOPMENTS

16.13 INFOSYS LIMITED

16.13.1 COMPANY SNAPSHOT

16.13.2 REVENUE ANALYSIS

16.13.3 SOLUTION PORTFOLIO

16.13.4 RECENT DEVELOPMENTS

16.14 MEDECISION

16.14.1 COMPANY SNAPSHOT

16.14.2 SOLUTION PORTFOLIO

16.14.3 RECENT DEVELOPMENT

16.15 MINES & ASSOCIATES, INC.

16.15.1 COMPANY SNAPSHOT

16.15.2 PRODUCT PORTFOLIO

16.15.3 RECENT DEVELOPMENT

16.16 NXGN MANAGEMENT, LLC

16.16.1 COMPANY SNAPSHOT

16.16.2 REVENUE ANALYSIS

16.16.3 PRODUCT PORTFOLIO

16.16.4 RECENT DEVELOPMENTS

16.17 PEGASYSTEMS INC.

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 SCIENCESOFT USA CORPORATION

16.18.1 COMPANY SNAPSHOT

16.18.2 INDUSTRY PORTFOLIO

16.18.3 RECENT DEVELOPMENTS

16.19 TCS HEALTHCARE TECHNOLOGIES

16.19.1 COMPANY SNAPSHOT

16.19.2 SERVICE PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 VIVIFY HEALTH, INC.

16.20.1 COMPANY SNAPSHOT

16.20.2 SOLUTION PORTFOLIO

16.20.3 RECENT DEVELOPMENTS

16.21 WELLSKY

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENTS

16.22 ZEOMEGA

16.22.1 COMPANY SNAPSHOT

16.22.2 PRODUCT PORTFOLIO

16.22.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

표 목록

TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)

TABLE 2 NEW CANCER CASES FOR AGE 85+ IN THE U.S.

TABLE 3 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)

TABLE 4 PRICES OF ESSENTIAL CHRONIC DISEASE MANAGEMENT SOLUTIONS

TABLE 5 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 6 ASIA-PACIFIC SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 ASIA-PACIFIC SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 9 ASIA-PACIFIC ON PREMISE SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 ASIA-PACIFIC WEB BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 ASIA-PACIFIC CLOUD BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE, 2019-2028 (USD MILLION)

TABLE 13 ASIA-PACIFIC IMPLEMENTATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 ASIA-PACIFIC CONSULTING SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 ASIA-PACIFIC EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 ASIA-PACIFIC EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 18 ASIA-PACIFIC CARDIOVASCULAR DISEASES (CVD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 ASIA-PACIFIC DIABETES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION 2019-2028 (USD MILLION)

TABLE 20 ASIA-PACIFIC CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 ASIA-PACIFIC ASTHMA IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 ASIA-PACIFIC ARTHRITIS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 ASIA-PACIFIC CANCER IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 ASIA-PACIFIC OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 26 ASIA-PACIFIC HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 ASIA-PACIFIC HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 28 ASIA-PACIFIC HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 ASIA-PACIFIC HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 30 ASIA-PACIFIC OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 32 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 33 ASIA-PACIFIC SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 34 ASIA-PACIFIC SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 35 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 36 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 37 ASIA-PACIFIC HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 38 ASIA-PACIFIC HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 39 CHINA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 40 CHINA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 41 CHINA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 42 CHINA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 43 CHINA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 44 CHINA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 45 CHINA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 46 JAPAN CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 47 JAPAN SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 48 JAPAN SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 49 JAPAN CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 50 JAPAN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 51 JAPAN HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 JAPAN HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 53 AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 54 AUSTRALIA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 55 AUSTRALIA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 56 AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 57 AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 58 AUSTRALIA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 59 AUSTRALIA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 60 INDIA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 61 INDIA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 62 INDIA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 63 INDIA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 64 INDIA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 65 INDIA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 66 INDIA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 67 SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 SOUTH KOREA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 69 SOUTH KOREA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 70 SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 71 SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 72 SOUTH KOREA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 73 SOUTH KOREA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 74 SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 75 SINGAPORE SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 76 SINGAPORE SERVICE TYPE IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 77 SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 78 SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 79 SINGAPORE HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 80 SINGAPORE HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 81 MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 82 MALAYSIA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 83 MALAYSIA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 84 MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 85 MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 86 MALAYSIA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 87 MALAYSIA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 88 THAILAND CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 89 THAILAND SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 90 THAILAND SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 91 THAILAND CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 92 THAILAND CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 93 THAILAND HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 94 THAILAND HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 95 INDONESIA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 96 INDONESIA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 97 INDONESIA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 98 INDONESIA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 99 INDONESIA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 100 INDONESIA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 101 INDONESIA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 102 PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 103 PHILIPPINES SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 104 PHILIPPINES SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 105 PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 106 PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 107 PHILIPPINES HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 108 PHILIPPINES HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 109 REST OF ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

그림 목록

FIGURE 1 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: MULTIVARIATE MODELLING

FIGURE 7 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: MARKET END USER COVERAGE GRID

FIGURE 11 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION

FIGURE 12 GROWING GERIATRIC POPULATION IS EXPECTED TO DRIVE THE ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 SOLUTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET

FIGURE 15 PREVALENCE OF CHRONIC DISEASES

FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLIONS)

FIGURE 17 NORTH AMERICA AGING POPULATION (IN MILLIONS)

FIGURE 18 EUROPE AGING POPULATION (IN MILLIONS)

FIGURE 19 ASIA-PACIFIC AGING POPULATION (IN MILLIONS)

FIGURE 20 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2020

FIGURE 21 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2019-2028 (USD MILLION)

FIGURE 22 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 23 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 24 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2020

FIGURE 25 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2019-2028 (USD MILLION)

FIGURE 26 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, CAGR (2021-2028)

FIGURE 27 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, LIFELINE CURVE

FIGURE 28 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2020

FIGURE 29 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2019-2028 (USD MILLION)

FIGURE 30 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, CAGR (2021-2028)

FIGURE 31 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, LIFELINE CURVE

FIGURE 32 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2020

FIGURE 33 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2019-2028 (USD MILLION)

FIGURE 34 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, CAGR (2021-2028)

FIGURE 35 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, LIFELINE CURVE

FIGURE 36 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2020

FIGURE 37 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2019-2028 (USD MILLION)

FIGURE 38 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, CAGR (2021-2028)

FIGURE 39 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 40 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: SNAPSHOT (2020)

FIGURE 41 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020)

FIGURE 42 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 43 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 44 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE (2021-2028)

FIGURE 45 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: COMPANY SHARE 2020 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.